Furthermore, a study on pancreatic cancer reported that a close proximity of immunosuppressive IL10+ myelomonocytes to cytotoxic granzyme-B+ CD8+ T-cells instead of PD-1+ CD4 + T-cells was associated with shorter survival in non-neoadjuvant treated patients [44]. This evidence concerns the gene CD8A and pancreatic neoplasm.